COMMUNIQUÉS West-GlobeNewswire

Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
17/08/2026
Dividend to be Paid Consistent with the Company's Cash Dividend Policy REHOVOT, Israel and HOBOKEN, N.J., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company [...]
SEED Therapeutics Nominated for 2026 Prix Galien USA “Best Start-Up” Award
17/08/2026
Second Consecutive Nomination Recognizes SEED’s Progress in Rational Molecular Glue Development and Targeted Protein Degradation Recognition Follows First-in-Human Proof of Mechanism for Lead RBM39 Degrader ST-01156 in [...]
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
17/08/2026
Combined company to operate as Slate Medicines and focus on advancing Slate's portfolio of next-generation migraine therapeutics Slate’s lead product candidate, SLTE-1009, is a clinical stage, potentially best-in-class [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
17/08/2026
Key recent and second quarter highlights include: Completed first-cycle FDA review of the Company’s ANDA for preservative-free ketamine with no drug-related major deficiencies. The sole remaining item, a manufacturer's [...]
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD
17/08/2026
– DURAVYU was non-inferior to on-label aflibercept control (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (≥ 15 letters) unrelated to [...]
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
17/08/2026
The New Mechanistic Findings Support Can-Fite’s Ongoing Phase IIb Study Design Following Positive Phase IIa Results Ramat Gan, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) ( [...]
InspireMD Reports Second Quarter 2026 Financial Results
17/08/2026
- Company to host investor conference call today, August 17 th , at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime [...]
GHK-Cu Peptide Launched By Kylo Peptides for Laboratory Research Applications
17/08/2026
Sheridan,Wyoming, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com ] has added GHK-Cu peptide to its catalog of laboratory research materials, expanding the range of copper-binding compounds [...]
Zelluna ASA: Notice of EGM – experienced international biotech executive proposed for election to the Board and Board member steps down
17/08/2026
Oslo, 17 August 2026: The Board of Directors of Zelluna ASA (the “Company”) hereby calls for an Extraordinary General Meeting to be held on 9 September 2026 at 13:00 CEST, regarding election of a new member of the [...]
AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026
17/08/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL SETTLEMENT AND DELIVERY OF SECURITIES ISSUED AS PART OF ITS €14.2 MILLION PRIVATE PLACEMENT ANNOUNCED ON AUGUST 10, 2026 Paris, August 17, 2026, 7.30am CET AB Science S. [...]
AB Science annonce le succès du règlement-livraison des titres émis dans le cadre de son placement privé de 14,2 millions d’euros annoncé le 10 aout 2026
17/08/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES DU REGLEMENT-LIVRAISON DES TITRES EMIS DANS LE CADRE DE SON PLACEMENT PRIVE DE 14,2 MILLIONS D’EUROS ANNONCE LE 10 AOUT 2026 Paris, 17 août 2026, 7h30 AB Science S.A. ( [...]
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
17/08/2026
Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; [...]
Breast Augmentation in Dubai - Why Surgical Planning Matters More Than the Implant
17/08/2026
DUBAI, United Arab Emirates, Aug. 17, 2026 (GLOBE NEWSWIRE) -- With demand for aesthetic treatments continuing to rise across the UAE, women are increasingly seeking procedures of breast augmentation in Dubai that [...]
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
17/08/2026
NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in [...]
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®
17/08/2026
— First global Phase III trial to show significant progression-free and overall survival benefits in this setting — — SAFFRON trial results reinforce TAGRISSO ® as the backbone therapy across EGFRm lung cancer — HONG [...]
Avicanna Reports Q2 2026 Financial Results
15/08/2026
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product sales QUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured TORONTO, Aug. 14, 2026 (GLOBE [...]
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
14/08/2026
ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on First-Line Immune Checkpoint Inhibitor (ICI) Therapy AACR 2026 Preclinical [...]
Baylor Genetics Provides Notice of Data Security Incident
14/08/2026
HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics recently identified a cybersecurity incident that impacted a limited portion of its information technology environment and certain individuals’ personal [...]
GuideAI Health Corp. Announces Frankfurt Stock Exchange Symbol: ZN0
14/08/2026
BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (" GuideAI " or the " Company ") (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on the Frankfurt Stock Exchange (“FSE”) [...]

Pages